Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study

Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study

Abstract Background Anti-calcitonin gene-related peptide monoclonal antibodies (CGRPmAbs) are a favourable option for patients with migraine who experience distressful headache disability and fail to respond to traditional preventive treatment options. However, since CGRPmAb has been available for o...

Full description

Bibliographic Details
Main Authors: Keiko Ihara, Seiya Ohtani, Narumi Watanabe, Nobuyuki Takahashi, Naoki Miyazaki, Kei Ishizuchi, Satoko Hori, Ryo Takemura, Jin Nakahara, Tsubasa Takizawa
Format: Article
Language:English
Published: BMC 2023-03-01
Series:The Journal of Headache and Pain
Subjects:
Migraine
Japan
CGRPmAbs
Headache
Erenumab
Galcanezumab
Online Access:https://doi.org/10.1186/s10194-023-01556-7

Similar Items

Similar Items